Real-Life Experience on the Effect of SGLT2 Inhibitors vs. Finerenone vs. Combination on Albuminuria in Chronic Kidney Disease

Background: There have been several recent advances in the care of patients with chronic kidney disease (CKD), including the use of sodium glucose cotransporter 2 (SGLT2) inhibitors and selective mineralocorticoid receptor antagonists (MRAs). There are very few data reporting the outcomes of these t...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Mohamad Hanouneh, Dustin Le, Bernard G. Jaar, Christina Tamargo, C. Elena Cervantes
Formato:	Artigo
Idioma:	Inglês
Publicado em:	MDPI AG 2024-06-01
coleção:	Diagnostics
Assuntos:	chronic kidney disease albuminuria SGLT2 inhibitors finerenone
Acesso em linha:	https://www.mdpi.com/2075-4418/14/13/1357
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!